Exhibit 10.3

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY […***…],
HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

 

SECOND AMENDMENT

 

Manufacturing and Supply Agreement between
W. R. Grace & Co.-Conn. and ChromaDex, Inc.

 

This Second Amendment to the Manufacturing and Supply Agreement (the
“Amendment”) is made and effective as of January 1, 2018 (the “Effective Date”)
by and between W. R. Grace & Co.-Conn.(“GRACE”) and ChromaDex. Inc.
(“ChromaDex”).

 

RECITALS

 

WHEREAS, GRACE and ChromaDex entered into a certain Manufacturing and Supply
Agreement effective January 1, 2016 (the “Agreement”), and an Amendment to the
Agreement effective February 27, 2017, whereby GRACE agreed to sell to ChromaDex
and ChromaDex agreed to purchase from GRACE […***…] defined in the
specifications contained in Exhibit A of the Quality Agreement between the
parties (the “Product”) pursuant to the terms and conditions set forth therein;

 

WHEREAS, GRACE and ChromaDex desire and wish to further amend the Agreement as
set forth herein, with the understanding that all other provisions of the
Agreement and Amendment shall remain unchanged.

 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, and in consideration of the mutual obligations
herein contained, the parties hereto agree as follows:

 

I.    Product

The definition of Product is deleted in its entirety and replaced with the
following:

 

“Product” shall mean the […***…] defined by the Specifications and,
collectively, refers to Product A and Product B. Products A and B are
specifically defined as follows:

 

·

“Product A” shall mean Product that […***…], followed by […***…], followed by
[…***…], and that […***…] in the Specification.

 

·

“Product B” shall mean Product that […***…], followed by […***…], followed by
[…***…], that […***…]in the Specification, and […***…].”

 

II.   Forecasts

The following is added as a new sentence at the end of Section 1(f):

 

“Notwithstanding any other terms of this Section 1(f) to the contrary, ChromaDex
shall provide reasonable prior written notice of any forecasted orders for
Product manufactured to compliance with 21 CFR Part 211.”

 

III.  Intermediate […***…]

The following is added as a new Section 1(l)(ii)(A):

 

“(A) Should Grace determine that the intermediate […***…]for Product […***…]
exceeds the […***…], Grace will provide notification by phone to the ChromaDex
contact person designated in the Quality Agreement by phone. ChromaDex will have
[…***…] from the time of such call (the “Response Period”) to inform Grace
whether to perform a […***…] on the applicable Product […***…]. If ChromaDex

 

 

1

 

 

does not respond within such time, Grace may, at its sole discretion perform
[…***…] and, with respect to each of the […***…] manufactured in calendar year
[…***…], the applicable price for that batch of Product will […***…]. Each
party’s obligations under the Agreement still withstanding, Grace shall have no
liability specifically with regards to such decision.”

 

The following is added as a new Section 1(I)(ii)(B):

 

“(B) Should ChromaDex respond within the Response Period and decide not to have
such Product […***…] undergo […***…], ChromaDex agrees that the […***…] for the
applicable batch of Product are acceptable and ChromaDex shall not reject such
batch of Product on the basis of to its […***…]. Each party’s obligations under
the Agreement still withstanding, Grace shall have no liability specifically
with regards to […***…] in such batch […***…].”

 

IV.  Purchase Obligations

The following is added to the end of the first paragraph of Section 4:

 

“ChromaDex shall purchase not less than […***…]of Product from GRACE during the
period […***…], and a total of not less than […***…]during the period […***…]and
a total of not less than […***…]during the period […***…]. GRACE shall make
commercially reasonable efforts to have the capacity to manufacture and supply
ChromaDex with […***…]of Product during the period […***…]. For avoidance of
doubt, ChromaDex’s obligations with respect to its rolling and binding forecasts
are not altered by any minimum purchase obligations.”

 

V.   Supply Continuity

Section 5 of the Agreement is amended to add a new paragraph 5(e):

 

“(e) The Parties will jointly use commercially reasonable efforts to identify
and target potential areas for cost reduction with respect to Product
manufacture. Representatives of the parties will meet not less than […***…] per
[…***…]to discuss and agree on such cost reduction efforts. […***…] […***…]
Ownership rights with respect to any information developed with respect to the
process of manufacturing Product shall be determined according to […***…] of the
Agreement.”

 

  2  

 

V.   Product Price

Exhibit B of the Agreement is deleted in its entirety and replaced by the
attached Exhibit B.

 

Except as amended and supplemented hereby, all of the terms and conditions of
the Agreement and Amendment shall remain and continue in full force and effect
and apply hereto. Capitalized terms not otherwise defined herein shall have the
meaning given in the Agreement. This Second Amendment shall become effective as
of the Effective Date when executed by the parties hereto.

 

IN WITNESS THEREOF, the authorized representatives of the parties have executed
this Second Amendment to the Manufacturing and Supply Agreement effective as of
the Effective Date.

 

W.R. Grace & Co.-Conn.

ChromaDex, Inc.

 

 

 

 

 

 

Signature:

/s/ Sandra L. Wisniewski

 

Signature:

/s/ Troy Rhonemus

 

Name:

Sandra L. Wisniewski

 

Name:

Troy Rhonemus

 

Title:

President, Materials Technologies

 

Title:

EVP

 

Date:

Jan 25, 2018

 

Date:

1/26/2018

 

 

  3  

 

Exhibit B: Purchase Price

 

The Product prices are as follows:

 

[…***…] produced in calendar year […***…]:

 

Product A

$[…***…]

Product B:

$[…***…]

 

If reprocessing is required for any of the […***…] produced in calendar year
[…***…] by way of a […***…] after the Product has been […***…] following an
[…***…], […***…]. If reprocessing is not required for any of the initial batches
by way of a […***…]after the Product has been […***…] following an […***…],
[…***…]:

 

Product A:

$[…***…]

 

 

Product B:

$[…***…]

 

For avoidance of doubt, the above-listed prices apply only to Product
manufactured to compliance with […***…]. The parties will meet to agree on
prices for Product manufactured to […***…].

 

  4